Publication: A comparative study on the genotoxic effect of pyrimethamine in bone marrow and spermatogonial mice cells
Date
Authors
Çelikler, Serap
Çinkılıç, Nilüfer
Bilaloǧlu, Rahmi
Authors
Advisor
Language
Type
Publisher:
Walter De Gruyter Gmbh
Journal Title
Journal ISSN
Volume Title
Abstract
Pyrimethamine is an antimalarial agent widely used in clinical therapy. We aimed to compare its mutagenic potential in mammalian spermatogonial and bone marrow cells. For studying chromosomal aberrations mice were treated acutely (single treatment) with 4 dose levels of pyrimethamine (5, 10, 20 and 40 mg/kg). Pyrimethamine was found to produce a significant increase in structural chromosomal aberrations after acute treatment in bone marrow cells of mice (p < 0.001). It also induced chromosome abnormalities in spermatogonial cells (p < 0.05) at the highest dose.
Description
Source:
Keywords:
Keywords
In-vivo mouse, Micronucleus test, Sperm morphology, Daraprim, Fragile sites, Induction, Mutagenicity, Teratogenicity, Spermatogenesis, Assays, Mammalia, Mus, Biochemistry & molecular biology, Pharmacology & pharmacy
Citation
Çelikler, S. vd. (2007). "A comparative study on the genotoxic effect of pyrimethamine in bone marrow and spermatogonial mice cells". Zeitschrift fur Naturforschung - Section C Journal of Biosciences, 62(9-10), 679-683.